Figure 6.
In vivo coagulation potential assessed by ROTEM in HA mice infused with D519V/E665V/K1813A and D519V/E665V FVIII mutants. WT-FVIII (2 μg/kg) or mutant; D519V/E665V/K1813A (0.25, 0.5, 1, and 2 μg/kg) or D519V/E665V (1 μg/kg), or phosphate-buffered saline (PBS) were infused to the HA mice. CaCl2 was added to citrated whole-blood samples obtained from HA mice, followed by a ROTEM assay. The (A) CT and (B) α-angle parameters in WT mice and HA mice are shown. Statistical analysis between WT-FVIII (2 μg/kg) and FVIII mutants or no FVIII administration was performed using Dunnett multiple comparison test. Significant differences are defined as P < .05 (∗P < .05 and ∗∗P < .01). Each data point represents an individual mouse. The straight line in each graph represents the mean values. ns, not significant.

In vivo coagulation potential assessed by ROTEM in HA mice infused with D519V/E665V/K1813A and D519V/E665V FVIII mutants. WT-FVIII (2 μg/kg) or mutant; D519V/E665V/K1813A (0.25, 0.5, 1, and 2 μg/kg) or D519V/E665V (1 μg/kg), or phosphate-buffered saline (PBS) were infused to the HA mice. CaCl2 was added to citrated whole-blood samples obtained from HA mice, followed by a ROTEM assay. The (A) CT and (B) α-angle parameters in WT mice and HA mice are shown. Statistical analysis between WT-FVIII (2 μg/kg) and FVIII mutants or no FVIII administration was performed using Dunnett multiple comparison test. Significant differences are defined as P < .05 (∗P < .05 and ∗∗P < .01). Each data point represents an individual mouse. The straight line in each graph represents the mean values. ns, not significant.

Close Modal

or Create an Account

Close Modal
Close Modal